CYP2C19 and transient ischemic attack: More recently, NICE has published diagnostic guidance recommending CYP2C19 genotyping in patients to guide treatment following ischemic stroke and transient ischemic attack (TIA; Diagnostic Guidance 59, https://www.nice.org.uk/guidance/dg59, last accessed November 6, 2024).